Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDescription:
This is a Single-center, diagnostic open-label prospective, pilot study in a total of 10 patients affected by Prostate cancer (PCa) with a risk of lymph node invasion (LNI) higher than 5% and candidates for a robot-assisted radical prostatectomy (RARP) with an extended pelvic lymph node dissection (ePLND) . The aim of the trial is to evaluate the feasibility and accuracy and clinical value of a novel high-resolution perioperative PET-CT-scan for intraoperative margin and lymph node invasion assessment, after 18F-PSMA injection, using histopathology as the gold standard.
Sponsor:
IRCCS San Raffaele
Contacts:
GIORGIO GANDAGLIA (CONTACT)gandaglia.giorgio@hsr.it
+39 02 26438068
LUCIA DAMBROSIO (CONTACT)dambrosio.lucia@hsr.it
Government Study Link:
NCT06298838 - Click here to see study onClinicalTrials.gov
Help us improve your experience